Polymyositis and dermatomyositis epidemiology and demographics: Difference between revisions
(→Race) |
(→Gender) |
||
Line 26: | Line 26: | ||
*There is no racial predilection to polymyositis and dermatomyositis. | *There is no racial predilection to polymyositis and dermatomyositis. | ||
===Gender=== | ===Gender=== | ||
*Females are more commonly affected by polymyositis and dermatomyositis than males. The female to male ratio is approximately 2 to 1. | *Females are more commonly affected by polymyositis and dermatomyositis than males. The female to male ratio is approximately 2 to 1.<ref name="DalakasHohlfeld2003">{{cite journal|last1=Dalakas|first1=Marinos C|last2=Hohlfeld|first2=Reinhard|title=Polymyositis and dermatomyositis|journal=The Lancet|volume=362|issue=9388|year=2003|pages=971–982|issn=01406736|doi=10.1016/S0140-6736(03)14368-1}}</ref> | ||
===Region=== | ===Region=== | ||
*Prevalence of polymyositis and dermatomyositis are lower in young rural men and higher in older urban women.<ref name="BernatskyJoseph2008">{{cite journal|last1=Bernatsky|first1=S|last2=Joseph|first2=L|last3=Pineau|first3=C A|last4=Belisle|first4=P|last5=Boivin|first5=J F|last6=Banerjee|first6=D|last7=Clarke|first7=A E|title=Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences|journal=Annals of the Rheumatic Diseases|volume=68|issue=7|year=2008|pages=1192–1196|issn=0003-4967|doi=10.1136/ard.2008.093161}}</ref> | *Prevalence of polymyositis and dermatomyositis are lower in young rural men and higher in older urban women.<ref name="BernatskyJoseph2008">{{cite journal|last1=Bernatsky|first1=S|last2=Joseph|first2=L|last3=Pineau|first3=C A|last4=Belisle|first4=P|last5=Boivin|first5=J F|last6=Banerjee|first6=D|last7=Clarke|first7=A E|title=Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences|journal=Annals of the Rheumatic Diseases|volume=68|issue=7|year=2008|pages=1192–1196|issn=0003-4967|doi=10.1136/ard.2008.093161}}</ref> |
Revision as of 15:27, 9 April 2018
Polymyositis and dermatomyositis Microchapters |
Differentiating Polymyositis and dermatomyositis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polymyositis and dermatomyositis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Polymyositis and dermatomyositis epidemiology and demographics |
FDA on Polymyositis and dermatomyositis epidemiology and demographics |
CDC on Polymyositis and dermatomyositis epidemiology and demographics |
Polymyositis and dermatomyositis epidemiology and demographics in the news |
Blogs on Polymyositis and dermatomyositis epidemiology and demographics |
Risk calculators and risk factors for Polymyositis and dermatomyositis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence of polymyositis and dermatomyositis is approximately 2 per 100,000 individuals worldwide.[1]
- In 2010, the incidence of polymyositis and dermatomyositis was estimated to be 1-1.3 cases per 100,000 individuals in Japan annually.[2]
Prevalence
- The prevalence of polymyositis and dermatomyositis is approximately 5-22 per 100,000 individuals worldwide.[1]
- In 2003, the prevalence of polymyositis and dermatomyositis was estimated to be 21.5 cases per 100,000 individuals in Quebec.[3]
- In 2010, the prevalence of polymyositis and dermatomyositis was estimated to be 13.2 cases per 100,000 individuals in Japan.[2]
Case-fatality rate/Mortality rate
- The 5-year survival rate for polymyositis is 75% and for dermatomyositis is 63%.[2]
- The median survival for polymyositis is 11.0 years and that for dermatomyositis is 12.3 years.[2]
Age
- Dermatomyositis commonly affects both children and adults.[4]
- Polymyositis commonly affects adults after second decades of their lives and it is rare among children.[4][5]
Race
- There is no racial predilection to polymyositis and dermatomyositis.
Gender
- Females are more commonly affected by polymyositis and dermatomyositis than males. The female to male ratio is approximately 2 to 1.[4]
Region
- Prevalence of polymyositis and dermatomyositis are lower in young rural men and higher in older urban women.[6]
References
- ↑ 1.0 1.1 Jacobson DL, Gange SJ, Rose NR, Graham NM (September 1997). "Epidemiology and estimated population burden of selected autoimmune diseases in the United States". Clin. Immunol. Immunopathol. 84 (3): 223–43. PMID 9281381.
- ↑ 2.0 2.1 2.2 2.3 Airio, A.; Kautiainen, H.; Hakala, M. (2006). "Prognosis and mortality of polymyositis and dermatomyositis patients". Clinical Rheumatology. 25 (2): 234–239. doi:10.1007/s10067-005-1164-z. ISSN 0770-3198.
- ↑ Bernatsky, S; Joseph, L; Pineau, C A; Belisle, P; Boivin, J F; Banerjee, D; Clarke, A E (2008). "Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences". Annals of the Rheumatic Diseases. 68 (7): 1192–1196. doi:10.1136/ard.2008.093161. ISSN 0003-4967.
- ↑ 4.0 4.1 4.2 Dalakas, Marinos C; Hohlfeld, Reinhard (2003). "Polymyositis and dermatomyositis". The Lancet. 362 (9388): 971–982. doi:10.1016/S0140-6736(03)14368-1. ISSN 0140-6736.
- ↑ Dalakas, Marinos C; Hohlfeld, Reinhard (2003). "Polymyositis and dermatomyositis". The Lancet. 362 (9388): 971–982. doi:10.1016/S0140-6736(03)14368-1. ISSN 0140-6736.
- ↑ Bernatsky, S; Joseph, L; Pineau, C A; Belisle, P; Boivin, J F; Banerjee, D; Clarke, A E (2008). "Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences". Annals of the Rheumatic Diseases. 68 (7): 1192–1196. doi:10.1136/ard.2008.093161. ISSN 0003-4967.